Healthplus.ai Raises €2.3M To Help Hospitals Predict Post-Surgery Infections

The funding round was led by Elevating Capital, with participation from LUMO Labs, ROM InWest, Pathena, and Leistone (Renza Family).

Healthplus.ai’s ISO- and CE-certified AI system, PERISCOPE, helps reduce post-surgery complications, mitigate their consequences, shorten recovery times, and lower hospital costs.

Marcel Broersma, Founding Partner of Elevating Capital, says, “The investment in Healthplus.ai fits seamlessly within our strategy to invest in technology-driven companies with a demonstrable social impact. Healthplus.ai combines medical expertise with AI to make clinical risks predictable and to improve the quality and efficiency of healthcare processes.”

Founded in 2017 by Bart Geerts and Bart Steverink, Healthplus.ai is a medical technology company dedicated to reducing surgical complications and supporting full recovery. Its CE-certified AI system, PERISCOPE, uses electronic health record (EHR) data to predict infection risk, enabling clinical teams to act early, limit preventable harm, and make safer discharge decisions.

Read Also - Noteless Raises €3.5M To Ease Doctors’ Administrative Work

Globally, one in three surgical patients experiences a complication affecting over 70 million people annually. Despite this, five billion people still lack access to safe, affordable surgical and anesthesia care, with infections remaining the most common and often late-identified source of complications.

PERISCOPE integrates seamlessly with hospital systems, aligns with routine clinical workflows, and adapts to each patient population to ensure consistent performance and regulatory compliance. By doing so, Healthplus.ai helps reduce complication-related costs and enhances the efficiency of surgical teams.

The company currently operates in the Netherlands, Belgium, Denmark, and the UK, and is preparing to expand across the Nordic region and North America, with early pilot programs already underway in the United States.

Healthplus.ai will use the funding to expand its presence in Europe and the US by pursuing FDA clearance, enhancing system integrations, and connecting its platform with major EHR providers like Epic, Cerner, and ChipSoft.

The company is also broadening its AI risk models to cover the full perioperative process and multiple types of complications.

Dr Bart Geerts, CEO and founder of Healthplus.ai, says, “With this late-seed investment, we’re strengthening our ability to bring clinically validated, regulatory-approved AI into everyday hospital practice. Our focus remains on close collaboration with surgeons, clinicians, and hospital IT teams to ensure that predictive insights truly improve patient outcomes.”

Roel Waals, Founding Partner of Elevating Capital, a new investor leading this key round, adds, “We see in this team strong execution capabilities, a scalable business model, and a clear contribution to the future of healthcare.”

About Healthplus.ai

Healthplus.ai develops AI tools that enable proactive, safer surgical care. Working closely with hospitals and healthcare institutions, the company delivers evidence-based technology that helps predict complications, support clinical decisions and improve patient outcomes. Its solutions bring practical innovation to real-world medical challenges enhancing efficiency and recovery across surgical pathways.